Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Structure and function of serotonin 5-HT2 receptors.

Shih JC, Chen K, Gallaher TK.

NIDA Res Monogr. 1994;146:284-97. Review. No abstract available.

PMID:
8742804
2.

Hallucinogens acting at 5-HT receptors: toward a mechanistic understanding at atomic resolution.

Weinstein H, Zhang D, Ballesteros JA.

NIDA Res Monogr. 1994;146:241-62. Review. No abstract available.

PMID:
8742802
3.

Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.

Westkaemper RB, Glennon RA.

NIDA Res Monogr. 1994;146:263-83. Review. No abstract available.

PMID:
8742803
4.

The use of rigid analogues to probe hallucinogen receptors.

Nichols DE, Weintraub HJ, Pfister WR, Yim GK.

NIDA Res Monogr. 1978;(22):70-83. No abstract available.

PMID:
101889
5.

Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain.

Aghajanian GK.

NIDA Res Monogr. 1994;146:183-202. Review. No abstract available.

PMID:
8742799
6.

[Molecular modeling of N-isopropyl lisergamides analogous to LSD using molecular mechanics and quantum mechanical calculations].

Cordero de Troconis MI, Pfaff R, Nichols D.

Acta Cient Venez. 1997;48(2):85-90. Spanish.

PMID:
9567327
7.

Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives.

Nichols DE, Shulgin AT, Dyer DC.

Life Sci. 1977 Aug 15;21(4):569-75. No abstract available.

PMID:
904435
8.

Serotonin receptor involvement in an animal model of the acute effects of hallucinogens.

Geyer MA, Krebs KM.

NIDA Res Monogr. 1994;146:124-56. Review. No abstract available.

PMID:
8742797
9.

Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.

Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE.

J Med Chem. 1997 Sep 12;40(19):2997-3008.

PMID:
9301661
10.

Recognition and activation of a 5-HT receptor by hallucinogens and indole derivatives.

Weinstein H, Osman R, Mercier G Jr.

NIDA Res Monogr. 1988;90:243-55. Review. No abstract available.

PMID:
2855856
11.

The mode of action of indolamine and other hallucinogens.

Boarder MR.

Essays Neurochem Neuropharmacol. 1977;2:21-48. Review. No abstract available.

PMID:
361385
12.

5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.

Roth BL, Willins DL, Kristiansen K, Kroeze WK.

Pharmacol Ther. 1998 Sep;79(3):231-57. Review.

PMID:
9776378
13.

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.

Marek GJ, Aghajanian GK.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):189-98. Review. No abstract available.

PMID:
9716940
14.

The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.

Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):75-82.

PMID:
10638639
15.

Serotonergic receptor subtypes and hallucinogen-induced stimulus control.

Winter JC, Fiorella DJ, Timineri DM, Filipink RA, Helsley SE, Rabin RA.

Pharmacol Biochem Behav. 1999 Oct;64(2):283-93. Review.

PMID:
10515304
16.
17.

Synthesis and 5-HT2A radioligand receptor binding assays of DOMCl and DOMOM, two novel 5-HT2A receptor ligands.

Harms A, Ulmer E, Kovar KA.

Arch Pharm (Weinheim). 2003 Jun;336(3):155-8.

PMID:
12822180
18.

5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.

López-Rodriguez ML, Benhamú B, Morcillo MJ, Murcia M, Viso A, Campillo M, Pardob L.

Curr Top Med Chem. 2002 Jun;2(6):625-41. Review.

PMID:
12052197
19.
20.

Supplemental Content

Support Center